Page 1 of 87
BASIC & CLINICAL PHARMACOLOGY (14TH EDITION) EXAM PREP 2026 SOLVED
QUESTIONS & ANSWERS WITH DETAILED RATIONALES VERIFIED 100 %
Basic & Clinical Pharmacology (14th Edition) — Questions
1. A drug that binds to a receptor and produces a maximal response is classified as
which of the following?
A. Partial agonist
B. Competitive antagonist
C. Full agonist
D. Inverse agonist
Correct Answer: C
Rationale: A full agonist binds to a receptor and produces a maximal biological
response. A partial agonist produces a submaximal response even at full receptor
occupancy. An inverse agonist produces an effect opposite to that of an agonist.
2. Which of the following best describes the term "bioavailability"?
A. The fraction of an administered drug dose that reaches the systemic circulation
unchanged
B. The volume of distribution of a drug
C. The rate of drug metabolism by the liver
D. The amount of drug excreted by the kidneys
, Page 2 of 87
Correct Answer: A
Rationale: Bioavailability (F) is the fraction of an administered drug dose that reaches
the systemic circulation in an unchanged form. IV administration has 100%
bioavailability.
3. A drug with a narrow therapeutic index requires which of the following?
A. Less frequent dosing
B. Therapeutic drug monitoring
C. Higher loading doses
D. Oral administration only
Correct Answer: B
Rationale: A narrow therapeutic index means the difference between therapeutic and
toxic doses is small. Therapeutic drug monitoring is essential to maintain drug levels
within the therapeutic range.
4. Which of the following pharmacokinetic parameters describes the apparent
volume into which a drug distributes in the body?
A. Clearance
B. Half-life
C. Volume of distribution
D. Bioavailability
Correct Answer: C
Rationale: Volume of distribution (Vd) is a theoretical volume that relates the amount of
drug in the body to its plasma concentration. It reflects the extent of drug distribution
into tissues.
5. A drug that is metabolized by zero-order kinetics demonstrates which of the
following characteristics?
, Page 3 of 87
A. A constant fraction of the drug is eliminated per unit time
B. A constant amount of the drug is eliminated per unit time
C. The elimination rate is proportional to drug concentration
D. The half-life is independent of dose
Correct Answer: B
Rationale: Zero-order kinetics (saturation kinetics) occurs when the elimination
pathways are saturated. A constant amount of drug is eliminated per unit time,
regardless of concentration. Phenytoin and ethanol are examples.
6. Which of the following best describes the first-pass effect?
A. Drug metabolism by the liver before reaching systemic circulation
B. Drug excretion by the kidneys
C. Drug distribution to the brain
D. Drug binding to plasma proteins
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of a drug by the liver (and gut
wall) before it reaches the systemic circulation. It reduces the bioavailability of orally
administered drugs.
7. A drug that is highly protein-bound will have which of the following
characteristics?
A. A large volume of distribution
B. A small volume of distribution
C. Rapid renal excretion
D. Enhanced hepatic metabolism
Correct Answer: B
Rationale: Drugs that are highly protein-bound remain largely in the vascular space,
, Page 4 of 87
resulting in a small volume of distribution. Only the free (unbound) fraction is
pharmacologically active.
8. Which of the following describes the mechanism of action of a competitive
antagonist?
A. It binds to the receptor and prevents the agonist from binding
B. It binds to the receptor and produces a partial response
C. It binds to a site other than the receptor and inhibits the agonist
D. It irreversibly inactivates the receptor
Correct Answer: A
Rationale: A competitive antagonist reversibly binds to the receptor at the same site as
the agonist, preventing agonist binding. Its effects can be overcome by increasing the
agonist concentration.
9. Which of the following is the primary organ responsible for drug
biotransformation?
A. Kidney
B. Liver
C. Lung
D. Intestine
Correct Answer: B
Rationale: The liver is the primary organ for drug biotransformation. It contains high
concentrations of cytochrome P450 enzymes and other metabolizing enzymes.
10. A drug that induces cytochrome P450 enzymes will have which effect on co-
administered drugs metabolized by the same enzymes?
A. Increased plasma levels of the co-administered drug
B. Decreased plasma levels of the co-administered drug
BASIC & CLINICAL PHARMACOLOGY (14TH EDITION) EXAM PREP 2026 SOLVED
QUESTIONS & ANSWERS WITH DETAILED RATIONALES VERIFIED 100 %
Basic & Clinical Pharmacology (14th Edition) — Questions
1. A drug that binds to a receptor and produces a maximal response is classified as
which of the following?
A. Partial agonist
B. Competitive antagonist
C. Full agonist
D. Inverse agonist
Correct Answer: C
Rationale: A full agonist binds to a receptor and produces a maximal biological
response. A partial agonist produces a submaximal response even at full receptor
occupancy. An inverse agonist produces an effect opposite to that of an agonist.
2. Which of the following best describes the term "bioavailability"?
A. The fraction of an administered drug dose that reaches the systemic circulation
unchanged
B. The volume of distribution of a drug
C. The rate of drug metabolism by the liver
D. The amount of drug excreted by the kidneys
, Page 2 of 87
Correct Answer: A
Rationale: Bioavailability (F) is the fraction of an administered drug dose that reaches
the systemic circulation in an unchanged form. IV administration has 100%
bioavailability.
3. A drug with a narrow therapeutic index requires which of the following?
A. Less frequent dosing
B. Therapeutic drug monitoring
C. Higher loading doses
D. Oral administration only
Correct Answer: B
Rationale: A narrow therapeutic index means the difference between therapeutic and
toxic doses is small. Therapeutic drug monitoring is essential to maintain drug levels
within the therapeutic range.
4. Which of the following pharmacokinetic parameters describes the apparent
volume into which a drug distributes in the body?
A. Clearance
B. Half-life
C. Volume of distribution
D. Bioavailability
Correct Answer: C
Rationale: Volume of distribution (Vd) is a theoretical volume that relates the amount of
drug in the body to its plasma concentration. It reflects the extent of drug distribution
into tissues.
5. A drug that is metabolized by zero-order kinetics demonstrates which of the
following characteristics?
, Page 3 of 87
A. A constant fraction of the drug is eliminated per unit time
B. A constant amount of the drug is eliminated per unit time
C. The elimination rate is proportional to drug concentration
D. The half-life is independent of dose
Correct Answer: B
Rationale: Zero-order kinetics (saturation kinetics) occurs when the elimination
pathways are saturated. A constant amount of drug is eliminated per unit time,
regardless of concentration. Phenytoin and ethanol are examples.
6. Which of the following best describes the first-pass effect?
A. Drug metabolism by the liver before reaching systemic circulation
B. Drug excretion by the kidneys
C. Drug distribution to the brain
D. Drug binding to plasma proteins
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of a drug by the liver (and gut
wall) before it reaches the systemic circulation. It reduces the bioavailability of orally
administered drugs.
7. A drug that is highly protein-bound will have which of the following
characteristics?
A. A large volume of distribution
B. A small volume of distribution
C. Rapid renal excretion
D. Enhanced hepatic metabolism
Correct Answer: B
Rationale: Drugs that are highly protein-bound remain largely in the vascular space,
, Page 4 of 87
resulting in a small volume of distribution. Only the free (unbound) fraction is
pharmacologically active.
8. Which of the following describes the mechanism of action of a competitive
antagonist?
A. It binds to the receptor and prevents the agonist from binding
B. It binds to the receptor and produces a partial response
C. It binds to a site other than the receptor and inhibits the agonist
D. It irreversibly inactivates the receptor
Correct Answer: A
Rationale: A competitive antagonist reversibly binds to the receptor at the same site as
the agonist, preventing agonist binding. Its effects can be overcome by increasing the
agonist concentration.
9. Which of the following is the primary organ responsible for drug
biotransformation?
A. Kidney
B. Liver
C. Lung
D. Intestine
Correct Answer: B
Rationale: The liver is the primary organ for drug biotransformation. It contains high
concentrations of cytochrome P450 enzymes and other metabolizing enzymes.
10. A drug that induces cytochrome P450 enzymes will have which effect on co-
administered drugs metabolized by the same enzymes?
A. Increased plasma levels of the co-administered drug
B. Decreased plasma levels of the co-administered drug
